The Infectious Diseases Anti-Parasitic pipeline is focused on exploiting the re-discovery of a lost medicinal plant to produce a first-in-class treatment for a wide spread and complex parasite. In-vitro testing of isolated compounds, fractions and optimised extracts have provided exceptionally good results with the parasite being affected in a completely new way to current drug treatments. Scientific studies: To see an overview of the R&D program and scientific studies comparing Bioactive extracts to other pharmaceutical substances click on Bioactive Research Drug development & licencing collaborations are currently being formed – this web page will be under development over the next few months whilst … Continue reading BL8-P382 – Infectious Diseases: Anti-Parasitic drug candidate